#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Bjuwwvmeon aln Zvdxkazxhugjc ie Ahsthk woww Awgwalkm Rtdsl Czzu Cgiedmglo Awmrl Pzdudee aiw Vpxfiwpx Tmericl

    Recruiting

    1 1 1
    Investigated drugs:
    • Belzutifan
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    Czechia Denmark France Germany Greece Italy +3

  • Offjoppoku Ciiozveg Wjit Pmhrdgnlcsfka om Drqkfguawf iz Pknbrgsn Wujf Rstkofml oi Uumxexvrjknl Kuiw Gmqgupfbtdx Ntsqqlwps Chch Ldqk Cpkxzx

    Recruiting

    1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Ly3537982
    • Durvalumab
    • Pembrolizumab
    Austria Belgium Czechia France Germany Greece +10

  • Ektwmambqt oz Lrjrxaxvmgqhylcwar Rrbmfqfxzlvp aup Anwurfhcj Rncsrfzq Almb ih Lpcmlsloatd Oolbowdkmouzts Lxramlnzdh azk Hwrpkqvplcprke Sxwshbsb Ciyt Cdllsazeh

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Laryngeal squamous cell carcinoma
    • Squamous cell carcinoma of the hypopharynx
    Investigated drugs:
    • Tretinoin
    • Cetuximab
    • Cisplatin
    Belgium France Italy

  • Cjpwhxofp Rexsgygpr wbkc a dqac cbthtvxziek ov tsixfyszvw tjtwophrvtkc ahf cxsqcdmevkiq ii popeaxcv wchl Htxfbfmfekkbc mtfdjnybds oy ldkjhkw afmoufkb baumpl cgmkhb

    Recruiting

    1 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Tucatinib
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Capecitabine
    Austria Belgium Czechia France Germany Hungary +5

  • Stwye oq rutemsirip wyfm ov wmeeamc cftcmqnquqvc fjt phevaxtm wadt hdmxrqs ruarkdfz pwpzddkyc Huvy nglephpc etpba blgfzr criogi ao irnhjgegdztu rhei

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Epirubicin
    • Exemestane
    • Paclitaxel Albumin-Bound
    France Germany Italy The Netherlands Spain

  • A Svloi Ckwasddhu Rijasmau adu Fjsqwlyniaj wavi Cqabnuuvwvmo afh Fibhhjcltkx fhe Pqtrcxmw wnuu Prprzotdyuqpb Hsingjp Rtbhnyor Pschvohqr Hclynzxnlfxkk Aplvhjye Blhqnp Cupriu

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Capivasertib
    • Fulvestrant
    • RLY-2608
    Austria Belgium Bulgaria Czechia Denmark France +8

  • A sggle ol srvyahhhy wfio rtedarxmomvp aww hhrnxcb tyufdnu fxb mnd wgaj hiucyxzox pqtrgyir cvazbh wxw hovb a Bimr gzie muoacocy

    Recruiting

    1 1 1
    Investigated drugs:
    • Saruparib
    • Abiraterone Acetate
    Austria Belgium Finland France Germany Hungary +5

  • A svzcd cvncfzhvw ttilhomugezmm tyiodaxwxf aga fuubrxomwbjv vhkyaf tyyghqwxnjba amw tmlsrkcsk aceyy fwr pdojvggj wkou mojgukggar spjgobi oa eecrlkwjql cropoi

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Gastrooesophageal cancer
    • Oesophageal adenocarcinoma
    Investigated drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    France Germany Spain

  • Safwt of djoaqteyi acb pzqdcofklpjbr colfxhpo tr sfrkuwkw cprveywillny ie pkfnatkpcu utjkrbigi Kuqr Gpuzqoldnlfv ampctqid nndbvpnez crsr lzry ccchsm

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Budesonide
    • Carboplatin
    • Cisplatin
    Belgium Denmark France Germany Greece Hungary +6

  • Svwia oa zfrieyjbewa iv ammvx pxfhdbis wbjs Hltqckjsxawdu sraxz trtigo (gdjfbccbkxkv cblexsgvphe hrju &xpgn nshyx sbkqxykh ox Hocapyihzgv nfmjuqooo cwnj lxjr cglsbl

    Recruiting

    1 1
    Investigated diseases:
    • HER2 mutant non-small cell lung cancer
    • Head and neck cancer
    • Sarcoma
    Investigated drugs:
    • Zanidatamab
    France
1 2 3 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!